Specifically, it has been shown that resveratrol reduces the production of RA-related angiogenic cytokines and inhibits glycolysis through the activation of SIRT1, thereby weakening the potential for angiogenesis (83). Here, SIRT1 is linked to rheumatoid arthritis.